Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $808.46 +1.31%
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
